Nowadays pancreatic cancer prognosis
Med Clin (Barc). 2019 May 17;152(10):395-396.
doi: 10.1016/j.medcli.2018.12.005.
Epub 2019 Feb 2.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Oncología Médica, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, España. Electronic address: anajgordo@hotmail.com.
- 2 Servicio de Oncología Médica, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, España.
No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Albumin-Bound Paclitaxel / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chemotherapy, Adjuvant
-
Comorbidity
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Diabetes Mellitus / epidemiology
-
Diet
-
Drug Resistance, Neoplasm
-
Early Detection of Cancer
-
Fluorouracil / administration & dosage
-
Gemcitabine
-
Genetic Predisposition to Disease
-
Humans
-
Irinotecan / administration & dosage
-
Leucovorin / administration & dosage
-
Neoadjuvant Therapy
-
Neoplasm Metastasis
-
Oxaliplatin / administration & dosage
-
Palliative Care
-
Pancreatectomy
-
Pancreatic Neoplasms / diagnosis
-
Pancreatic Neoplasms / etiology
-
Pancreatic Neoplasms / mortality*
-
Pancreatic Neoplasms / therapy
-
Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use
-
Prognosis
-
Radiosurgery
-
Risk Factors
-
Spain / epidemiology
Substances
-
Albumin-Bound Paclitaxel
-
Poly(ADP-ribose) Polymerase Inhibitors
-
folfirinox
-
Oxaliplatin
-
Deoxycytidine
-
Irinotecan
-
Leucovorin
-
Fluorouracil
-
Gemcitabine